GMT — Genomtec SA Income Statement
0.000.00%
Last trade - 00:00- PLN91.89m
- PLN83.96m
- PLN0.00m
Annual income statement for Genomtec SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | PRESS | ARS | ARS | ARS |
| Standards: | IFRS | — | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.02 | 0.219 | 0.04 | 0.001 | 0.001 |
| Cost of Revenue | |||||
| Gross Profit | -3.51 | -0.455 | -3.23 | -0.793 | -4.31 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 10.9 | 5.86 | 11.5 | 8.73 | 11.1 |
| Operating Profit | -10.9 | -5.64 | -11.5 | -8.73 | -11.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -10.9 | -5.75 | -11.9 | -9.03 | -11.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -10.9 | -5.27 | -11.9 | -9.01 | -11.2 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -10.9 | -5.27 | -11.9 | -9.01 | -11.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -10.9 | -5.27 | -11.9 | -9.01 | -11.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.34 | -0.646 | -1.27 | -0.735 | -0.841 |
| Dividends per Share |